University General Hospital of Alexandroupoli ( Site 1206) — Alexandroupoli, East Macedonia and Thrace

Public research footprint of University General Hospital of Alexandroupoli ( Site 1206), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer (NSCLC) · Hepatitis B, Chronic · Diffuse Large B-Cell Lymphoma · Acute Myeloid Leukemia (AML)

Recently updated registry entries

NCT07554339 — A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell… (Recruiting)
NCT06152575 — MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People… (Recruiting)
NCT07564414 — A Research Study to Look at How Two Different Doses of CagriSema and One Dose of… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University General Hospital of Alexandroupoli ( Site 1206)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.